The United States already buys Israeli technology. It buys it late, episodically, and usually after a company has spent years finding its own way into the American market. Delegations visit Tel Aviv, get impressed, fly home, and the impression dissipates into the normal friction of procurement. What does not exist is a standing mechanism whose job is to find Israeli dual-use companies early, translate American mission needs into terms a founder can build against, and move capital when the fit is real. That gap is not a market failure in the abstract. It is a specific institutional absence, and the United States has already invented the institution that fills it.
The sourcing-trip problem
Every serious national security technology organization in Washington knows Israel matters. The knowledge produces activity — conferences, memoranda of understanding, innovation-office visits — but activity is not a pipeline. A sourcing trip discovers whatever happens to be visible that week: the companies with polished English-language decks, the founders with existing U.S. networks, the sectors currently fashionable. It systematically misses the company two years from visibility, which is precisely the company where early strategic capital changes the outcome.
The deeper problem is translation. Israeli founders build for the customer in front of them, and the customer in front of them is usually the Israeli defense establishment or the global commercial market. American mission demand — the specific operational problems of U.S. agencies and services — reaches them as rumor, filtered through consultants and secondhand procurement folklore. A founder who would gladly build toward an American requirement often cannot find out what the requirement actually is. Demand exists; supply exists; the wire between them does not. Episodic engagement cannot hold that wire. Only an institution can.
The In-Q-Tel precedent
The United States solved a structurally identical problem once before. In the late 1990s, the intelligence community concluded that commercial technology was outrunning government development and that no procurement reform would close the gap fast enough. The answer was In-Q-Tel: a mission-driven strategic investor that sits between government demand and startup supply, invests real capital on commercial terms, and — this is the part imitators miss — pairs every investment with work to connect the company to an actual government user. The equity is not the point. The equity is the instrument that earns the investor a seat inside the company's roadmap, so that mission requirements shape the product while the product is still soft.
I led dual-use investment work at IQT and championed its first investment in Israel, so I hold the model's strengths and limits without romance. The model works because it changes incentives on both sides of the wire. Government partners get a scout with skin in the game rather than a briefing. Founders get a counterparty who can say, concretely, what the mission needs and who will pilot it — which is worth more than the check. And the discipline of commercial terms keeps the whole thing honest: if no venture investor will co-invest, that is information, and a mission-driven investor should treat it as such.
What the model has never had is a dedicated allied aperture. IQT's mandate is the U.S. mission, and it engages foreign ecosystems opportunistically, one deal at a time. Israel is not an opportunistic ecosystem. It is the densest concentration of dual-use founding talent outside the United States, embedded in a treaty-grade security relationship, producing companies in exactly the domains — cyber, AI, autonomy, sensing, secure infrastructure — where U.S. mission demand is most acute. Treating that as a place you occasionally visit is a category error.
What a dedicated mechanism actually does
Strip away the funding-vehicle vocabulary and a dedicated U.S.-Israel mechanism performs three functions no existing actor performs together. First, identification: a standing presence in the Israeli ecosystem that sees companies at formation, reads the technical teams accurately, and filters for genuine dual-use relevance rather than defense-flavored marketing. Second, translation: converting classified-adjacent American mission problems into unclassified technical requirements a foreign founder can legally and practically build against, and converting Israeli operational experience into terms an American program office can evaluate. Third, pathway: a repeatable route into allied markets — pilots, compliance scaffolding, facility clearances where warranted, introductions that carry institutional weight — so that each company does not have to reinvent market entry from zero.
The venture return matters, but as exhaust rather than engine. A mechanism that only optimized returns would be an ordinary fund with a flag on it, and ordinary funds already exist. The strategic output is the pipeline itself: a growing set of Israeli companies whose products were shaped early by allied mission demand and whose cap tables and compliance postures were built for the U.S. government market from the start, instead of being retrofitted painfully at Series C.
Where the pipeline already runs dry
The need is visible company by company. Across the startup database, the recurring pattern in defense, cybersecurity, and AI is a team with real operational pedigree, a working system proven in Israeli conditions, and no structured route to the American mission customer who needs it most. The same pattern extends to semiconductors, cloud infrastructure, and robotics, where Israeli companies build components and platforms the U.S. defense industrial base will eventually consume — but currently discovers only after a prime contractor or hyperscaler has already set the terms. Each company solves market entry alone, expensively, with survivorship bias doing the selection. A dedicated mechanism converts that lottery into a system.
The counterargument writes itself: Israeli companies already raise American money, so why does Washington need a special vehicle? Because generic venture capital optimizes for the fastest path to revenue, and the fastest path is almost never the U.S. government. Left to ordinary incentives, the most strategically relevant Israeli companies drift toward commercial markets and, at the margin, toward whatever capital asks the fewest questions. A mission-driven investor exists to bend that drift — to make the allied government market reachable early enough that founders build for it. That is not a subsidy. It is demand signaling with a term sheet attached.
What this means for investors
For private investors, the existence or absence of this mechanism is itself diligence-relevant. A dual-use company's value depends heavily on whether a credible channel into government adoption exists; where no institutional bridge operates, the investor must underwrite the company's ability to build that bridge alone, which is slow, capital-hungry, and binary. When screening companies in the database, the questions follow directly. Has the company had structured exposure to U.S. mission demand, or is its American strategy a hope and a hired lobbyist? Is the cap table clean enough for allied government work — no capital that would fail a foreign-ownership review? Does the team understand that selling to the U.S. government is a compliance posture, not a sales motion? Companies that answer well are positioned to capture the bridge when it is built. Companies that answer badly are pricing in a market they cannot actually reach — a distinction the site's alliance thesis treats as central.
Bottom line
The U.S.-Israel technology relationship runs on improvisation: talented founders finding their own way to American customers, agencies discovering allied capability by accident, capital flowing without mission context. Improvisation produced real successes, which is exactly why it persists. But the strategic environment no longer tolerates the waste. The In-Q-Tel model proved that a mission-driven investor can hold the wire between government demand and startup supply; what remains is to apply that proven structure to the single richest allied ecosystem the United States has. A dedicated mechanism would not replace the market. It would give the market a mission — and give investors, for the first time, a legible answer to the question of how an Israeli dual-use company actually reaches the customer its technology was built for.
Where this argument started
A shorter version of this argument first appeared as “U.S. national security needs a dedicated venture fund for Israeli innovation” in The Times of Israel (July 2025). This research edition expands the argument with database context, diligence framing, and internal links for readers who want to act on it.